A Study of Rilematovir (JNJ-53718678) in Adult Outpatients With Respiratory Syncytial Virus (RSV) Infection

NCT04978337 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
5
Enrollment
INDUSTRY
Sponsor class

Stopped Janssen made the strategic decision to discontinue the PRIMROSE study. This decision is not based on any safety concerns.

Conditions

Interventions

Sponsor

Janssen Research & Development, LLC